Sanova Tech builds a connected on-body drug delivery platform, enabling decentralized care for patients receiving high-volume biologic therapies. We believe care should be accessible, affordable, and built around the needs of the patient.

Chronic disease patients receiving high-volume biologic therapies face a persistent burden: every clinic visit consumes hours, for a therapy that could be administered at home. Sanova Tech closes that gap with three components. A delivery device enables self-administration at home. A biosensor monitors biomarkers, giving visibility into the treatment journey. A data analytics layer converts this into real-world therapy insight for practitioners and pharma partners.

Sanova Tech emerged from a Stanford professor led deep-tech accelerator and completed Cornell Research and Innovation's Hardware Prototyping Accelerator, where the team built its first functional prototype. A provisional patent was filed in 2025. Learn more at www.sanova-tech.com.